Search
Neurocrine Biosciences Inc
NBIXAdd to Watchlist
158.290USD
-0.710-0.45%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
15.92BMarket Cap
23.63P/E TTM
Neurocrine Biosciences Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Neurocrine Biosciences Inc is 7.97, ranking 113 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 23.63, which is 554.71% below the recent high of 154.68 and 5.50% above the recent low of 22.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
